Inhibitory effect of rivaroxaban on protease-activated receptor-2 in circulating neutrophils among patients with atrial fibrillation.

Nakano, Makoto; Yasuda, Satoshi; Hasebe, Yuhi; Nochioka, Kotaro; Fukuda, Koji; Takahashi, Jun; Shimokawa, Hiroaki

Nakano, Makoto; Yasuda, Satoshi; Hasebe, Yuhi; Nochioka, Kotaro; Fukuda, Koji; Takahashi, Jun; Shimokawa, Hiroaki.

Afiliação

Nakano M; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yasuda S; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hasebe Y; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Nochioka K; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Fukuda K; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Takahashi J; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Shimokawa H; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Int J Cardiol Heart Vasc ; 52: 101387, 2024 Jun.

Article em En | MEDLINE | ID: mdl-38854744

Palavras-chave

Direct oral anticoagulants; Protease-activated-receptor

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Cardiol Heart Vasc Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão País de publicação: Irlanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google